FACULTY
Prof Zahinoor ISMAIL
University of Calgary, Canada
Dr Zahinoor Ismail is a Clinician Scientist and Professor of Psychiatry, Neurology, Epidemiology, and Pathology at the Hotchkiss Brain Institute and O’Brien Institute for Public Health, at the University of Calgary. He has certification in Behavioral Neurology & Neuropsychiatry, and Geriatric Psychiatry, and his research includes: i) rating scale development and measurement-based care; ii) non-cognitive markers of dementia; iii) neuroimaging and biomarker studies; and iv) clinical trials. He is funded by Brain Canada, the Canadian Consortium on Neurodegeneration in Aging, and the Canadian Institutes of Health Research.
Dr Ismail is Chair of the Canadian Conference on Dementia, and Chair of the Canadian Consensus Conference on Diagnosis and Treatment of Dementia, which generates Canadian dementia guidelines, last published in 2020. Dr Ismail is past Academic Chair of the Alzheimer’s Association-ISTAART Neuropsychiatric Syndromes Professional Interests Area and led the ISTAART development of the neurobehavioural syndrome Mild Behavioural Impairment (MBI) and the MBI Checklist; he also co-led development of the new research criteria for biomarker and phenotypic classification of psychosis in AD and related dementias. In 2023, Dr. Ismail was appointed by the Minister of Health to serve as Co-Chair of the Government of Canada Ministerial Advisory Board for Dementia.
Session Involved
Dr Zahinoor Ismail is a Clinician Scientist and Professor of Psychiatry, Neurology, Epidemiology, and Pathology at the Hotchkiss Brain Institute and O’Brien Institute for Public Health, at the University of Calgary. He has certification in Behavioral Neurology & Neuropsychiatry, and Geriatric Psychiatry, and his research includes: i) rating scale development and measurement-based care; ii) non-cognitive markers of dementia; iii) neuroimaging and biomarker studies; and iv) clinical trials. He is funded by Brain Canada, the Canadian Consortium on Neurodegeneration in Aging, and the Canadian Institutes of Health Research.
Dr Ismail is Chair of the Canadian Conference on Dementia, and Chair of the Canadian Consensus Conference on Diagnosis and Treatment of Dementia, which generates Canadian dementia guidelines, last published in 2020. Dr Ismail is past Academic Chair of the Alzheimer’s Association-ISTAART Neuropsychiatric Syndromes Professional Interests Area and led the ISTAART development of the neurobehavioural syndrome Mild Behavioural Impairment (MBI) and the MBI Checklist; he also co-led development of the new research criteria for biomarker and phenotypic classification of psychosis in AD and related dementias. In 2023, Dr. Ismail was appointed by the Minister of Health to serve as Co-Chair of the Government of Canada Ministerial Advisory Board for Dementia.